Calcification Locates to Transglutaminases in Advanced Human Atherosclerotic Lesions
AUTOR(ES)
Matlung, Hanke L.
FONTE
American Society for Investigative Pathology
RESUMO
Transglutaminases play an important role in vascular smooth muscle cell-induced calcification in vitro. In this study, we determined whether these enzymes are also involved in human atherosclerotic calcification using nine carotid artery specimens obtained at endarterectomy. Sections of the carotid artery specimens were registered to micro-computed tomography images and stained for tissue-type transglutaminase, plasma transglutaminase factor XIIIA (FXIIIA), the Nε(γ-glutamyl)lysine cross-link, and the macrophage marker CD68. Ex vivo micro-computed tomography revealed extensive calcification, which significantly correlated with the cross-link. FXIIIA was found to be the dominant transglutaminase, rather than tissue-type transglutaminase, although staining of both transglutaminases correlated with the cross-link. Staining for FXIIIA colocalized with CD68 at both the cellular and tissue level. In conclusion, areas of calcification locate to the presence and activity of transglutaminases in human atherosclerotic arteries. FXIIIA seems to be the dominant transglutaminase and may be derived from local macrophages. These results are consistent with the hypothesis that transglutaminases participate in the calcification process of human atherosclerotic arteries.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2751534Documentos Relacionados
- Differential Effects of Pioglitazone on Advanced Atherosclerotic Lesions
- Bone morphogenetic protein expression in human atherosclerotic lesions.
- High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.
- Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
- Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques.